Method for culturing postnatal substantia nigra as an in vitro model of experimental Parkinson's disease

被引:17
|
作者
Smeyne, M [1 ]
Smeyne, RJ [1 ]
机构
[1] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA
来源
BRAIN RESEARCH PROTOCOLS | 2002年 / 9卷 / 02期
关键词
substantia nigra; Parkinson's disease; cell culture; N-methyl-4-phenyl-1,2,3,6 tetrahydropyridine hydrochloride (MPTP); glia; mice;
D O I
10.1016/S1385-299X(02)00117-4
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
One of the most prevalent degenerative disorders of the nervous system is Parkinson's disease. The etiology of this disease is for the most part unknown, although it is posited to arise from an interaction of genetic and environmental factors. Although in vivo animal studies have been used to examine the effects of a number of Parkinson-inducing compounds, there is little information on reliable in vitro methodologies that can recapitulate the previously observed in vivo results. Here, we describe a method for generating mixed and chimeric neuron/glial cultures of postnatal substantia nigra (SN), independent of other monoaminergic nuclei in the ventral midbrain. Since many toxins do not affect regions of the midbrain except the SN, use of whole ventral midbrain from embryos can dilute any measurement of cell death. By specifically culturing ventrolateral midbrain containing the substantia nigra, one can more directly target the effects of dopaminergic toxins. In addition, this method can be used to test potential therapies for amelioration of Parkinson's disease. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:105 / 111
页数:7
相关论文
共 50 条
  • [1] Postnatal decrease in substantia nigra echogenicityImplications for the pathogenesis of Parkinson’s disease
    Alexander Iova
    Andrew Garmashov
    Natalia Androuchtchenko
    Martin Kehrer
    Daniela Berg
    Georg Becker†
    Yurii Garmashov
    Journal of Neurology, 2004, 251 : 1451 - 1454
  • [2] Postnatal decrease in substantia nigra echogenicity - Implications for the pathogenesis of Parkinson's disease
    Iova, A
    Garmashov, A
    Androuchtchenko, N
    Kehrer, M
    Berg, D
    Becker, G
    Garmashov, Y
    JOURNAL OF NEUROLOGY, 2004, 251 (12) : 1451 - 1454
  • [3] Hyperechogenicity of the substantia nigra in Parkinson's disease
    Ressner, Pavel
    Skoloudik, David
    Hlustik, Petr
    Kanovsky, Petr
    JOURNAL OF NEUROIMAGING, 2007, 17 (02) : 164 - 167
  • [4] Substantia nigra hyperechogenicity in Parkinson’s disease
    Edson Bor-Seng-Shu
    Erich Talamoni Fonoff
    Egberto Reis Barbosa
    Manoel Jacobsen Teixeira
    Acta Neurochirurgica, 2010, 152 : 2085 - 2087
  • [5] Ultrasonography of the substantia nigra in Parkinson's disease
    Ressner, P.
    Skoloudik, D.
    Kanovsky, P.
    MOVEMENT DISORDERS, 2006, 21 : S615 - S615
  • [6] Substantia nigra hyperechogenicity in Parkinson's disease
    Bor-Seng-Shu, Edson
    Fonoff, Erich Talamoni
    Barbosa, Egberto Reis
    Teixeira, Manoel Jacobsen
    ACTA NEUROCHIRURGICA, 2010, 152 (12) : 2085 - 2087
  • [7] Hyperechogenicity of the substantia nigra in Parkinson's disease
    Ressner, P
    Skoloudik, D
    Kanovsky, P
    NEUROLOGY, 2006, 66 (05) : A114 - A114
  • [8] Organochlorine insecticides in substantia nigra in Parkinson's disease
    Corrigan, FM
    Wienburg, CL
    Shore, RF
    Daniel, SE
    Mann, D
    JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A, 2000, 59 (04): : 229 - 234
  • [9] Ultrasonography of substantia nigra (SN) in Parkinson's disease
    Ressner, P.
    Skoloudik, D.
    Kanovsky, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 81 - 82
  • [10] FETAL SUBSTANTIA NIGRA GRAFTS FOR PARKINSON′S DISEASE
    吴承远
    鲍秀峰
    张庆林
    李福增
    山东医科大学学报, 1993, (03) : 264 - 270